High Rates of Minimally Invasive Hysterectomy Surgery for Endometrial Cancer at National Comprehensive Cancer Network Centers

Objectives: Minimally invasive surgery (MIS) is considered a quality measure for the treatment of primary, stage I-III endometrial cancer (EC) by the Society of Gynecologic Oncology and the American College of Surgeons Commission on Cancer. In 2017, the National Comprehensive Cancer Network (NCCN) stated MIS hysterectomy is “the preferred approach” in the treatment of early-stage disease. Recent studies suggest only 50% of hysterectomies are performed via MIS and are less likely to be performed in the elderly or obese, racial minorities, those with aggressive tumor histologies, or in low EC volume hospitals. Therefore, a nationwide disparity in EC surgical care exists. Our study objective was to assess the percentage of EC cases performed by MIS at high-volume, NCCN centers and an evaluation of perioperative outcomes.